High-Density Lipoprotein and Heart Failure
Reviews in Cardiovascular Medicine · 21.11.2023 · 24 (11)
DOI: 10.31083/j.rcm2411321 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 21.11.2023. Verfasst von Liyun Xing und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the Second Hospital of Shandong University, 250033 Jinan, Shandong, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Medical Society and Technology Innovation Project of Jinan City, Science and Technology Innovation Project of Jinan City, Major Research and Development Project of Shandong Province.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
The protective effect of high-density lipoprotein (HDL) on atherosclerosis is well known, and its mechanisms of action has been extensively studied. However, the impact of HDL on heart failure and its mechanisms are still controversial or unknown. The cardioprotective role of HDL may be reflected in its antioxidant, anti-inflammatory, anti-apoptotic, and endothelial function protection. In epidemiological studies, high-density lipoprotein cholesterol (HDL-C) levels have been negatively associated with heart failure (HF). The major protein component of HDL-C is apolipoprotein (Apo) A-I, while paraoxonase-1 (PON-1) is an essential mediator for many protective functions of HDL, and HDL may act through components like (Apo) A-I or PON-1 to delay heart failure progress. HDL can slow heart failure disease progression through parts like (Apo) A-I or PON-1. The potential causality between HDL and heart failure, the role of HDL in the pathogenesis of HF, and its interaction with C-reactive protein (CRP), triglycerides (TG), and monocytes in the process of heart failure have been briefly summarized and discussed in this article. HDL plays an important role in the pathogenesis, progression and treatment of HF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, the Second Hospital of Shandong University, 250033 Jinan, Shandong, China.
- School of Clinical and Basic Medicine, Shandong First Medical University, 250117 Jinan, Shandong, China.
Förderung
- Clinical Medical Society and Technology Innovation Project of Jinan City
- Science and Technology Innovation Project of Jinan City
- Major Research and Development Project of Shandong Province
- Natural fund project of Shandong Province
- Central Government Guides Local Science and Technology Development
- National Natural Science Foundation of China
- New 20 Measures for Universities in Jinan City funded by Jinan Municipal Science and Technology Project
Zitieren
APA
Xing, L., Liu, Y., Wang, J., Tian, P., & Liu, P. (2023). High-Density Lipoprotein and Heart Failure. Reviews in Cardiovascular Medicine, 24(11). https://doi.org/10.31083/j.rcm2411321
Vancouver
Xing L, Liu Y, Wang J, Tian P, Liu P. High-Density Lipoprotein and Heart Failure. Reviews in Cardiovascular Medicine. 2023;24(11). doi:10.31083/j.rcm2411321
BibTeX
@article{Xing2023,
author = {Xing, Liyun and Liu, Yixuan and Wang, Jiayu and Tian, Peiqing and Liu, Ping},
title = {High-Density Lipoprotein and Heart Failure},
journal = {Reviews in Cardiovascular Medicine},
year = {2023},
volume = {24},
number = {11},
doi = {10.31083/j.rcm2411321}
}
EUVIMED